Showing results (3041-3050 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancerHaowei Wang, Lei Cheng, Jian Chen, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapyNijun Chen, Yuan Zong, Chen Yang, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2024
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) databaseZhaohui Li, Zixiang Zhou, Nan Zhang, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2024
Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapyShicheng Wang, Peng Peng, Junjun Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 11, 2024
Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphomaJiaying Wu, Wanying Liu, Yang Cao, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2024
Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockadeVictoria E Stefan, Daniela D Weber, Roland Lang, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2024
Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumorSoyoko Morimoto, Yukie Tanaka, Jun Nakata, et al.
Cancer Immunology, Immunotherapy : CII|November 5, 2024
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunityTomoko Ohtani, Shinji Kuroda, Nobuhiko Kanaya, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2025
The prognosis prediction value of CD69+ CD8+ tissue-resident memory T cell as a novel indicator of pathologic complete response heterogeneity following different neoadjuvant therapy regimen in esophageal squamous cell carcinomaAo Liu, Defeng Liu, Xiuli Liu, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2025
Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironmentYuze Zhao, Yuguang Song, Weiping Li, et al.
Pageof 652